The global Rheumatic Disorders Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Rheumatic Disorders Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatic Disorders Treatment.

Report Scope

The Rheumatic Disorders Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rheumatic Disorders Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rheumatic Disorders Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Rheumatic Disorders Treatment Market Report

Report Metric	Details
Report Name	Rheumatic Disorders Treatment Market
CAGR	5%
Segment by Type	Acts on TNF-α Acts on Interleukins and Interleukin Receptors Act on Protein Kinase Against Cell Surface Antigens Acts on Hormones and Hormone Receptors
Segment by Application	Hospital Pharmacy Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Humira, Enbrel, Simponi, Remicade, Rituxan, Stelara, Cosentyx, Prolia, Orencia, Actemra, Benlysta, Forteo
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rheumatic Disorders Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rheumatic Disorders Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rheumatic Disorders Treatment Market report?

Ans: The main players in the Rheumatic Disorders Treatment Market are Humira, Enbrel, Simponi, Remicade, Rituxan, Stelara, Cosentyx, Prolia, Orencia, Actemra, Benlysta, Forteo

What are the Application segmentation covered in the Rheumatic Disorders Treatment Market report?

Ans: The Applications covered in the Rheumatic Disorders Treatment Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the Rheumatic Disorders Treatment Market report?

Ans: The Types covered in the Rheumatic Disorders Treatment Market report are Acts on TNF-α, Acts on Interleukins and Interleukin Receptors, Act on Protein Kinase, Against Cell Surface Antigens, Acts on Hormones and Hormone Receptors

1 Rheumatic Disorders Treatment Market Overview

1.1 Product Overview and Scope of Rheumatic Disorders Treatment

1.2 Rheumatic Disorders Treatment Segment by Type

1.2.1 Global Rheumatic Disorders Treatment Market Value Comparison by Type (2024-2030)

1.2.2 Acts on TNF-α

1.2.3 Acts on Interleukins and Interleukin Receptors

1.2.4 Act on Protein Kinase

1.2.5 Against Cell Surface Antigens

1.2.6 Acts on Hormones and Hormone Receptors

1.3 Rheumatic Disorders Treatment Segment by Application

1.3.1 Global Rheumatic Disorders Treatment Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Other

1.4 Global Rheumatic Disorders Treatment Market Size Estimates and Forecasts

1.4.1 Global Rheumatic Disorders Treatment Revenue 2019-2030

1.4.2 Global Rheumatic Disorders Treatment Sales 2019-2030

1.4.3 Global Rheumatic Disorders Treatment Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Rheumatic Disorders Treatment Market Competition by Manufacturers

2.1 Global Rheumatic Disorders Treatment Sales Market Share by Manufacturers (2019-2024)

2.2 Global Rheumatic Disorders Treatment Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Rheumatic Disorders Treatment Average Price by Manufacturers (2019-2024)

2.4 Global Rheumatic Disorders Treatment Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Rheumatic Disorders Treatment, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Rheumatic Disorders Treatment, Product Type & Application

2.7 Rheumatic Disorders Treatment Market Competitive Situation and Trends

2.7.1 Rheumatic Disorders Treatment Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Rheumatic Disorders Treatment Players Market Share by Revenue

2.7.3 Global Rheumatic Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Rheumatic Disorders Treatment Retrospective Market Scenario by Region

3.1 Global Rheumatic Disorders Treatment Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Rheumatic Disorders Treatment Global Rheumatic Disorders Treatment Sales by Region: 2019-2030

3.2.1 Global Rheumatic Disorders Treatment Sales by Region: 2019-2024

3.2.2 Global Rheumatic Disorders Treatment Sales by Region: 2025-2030

3.3 Global Rheumatic Disorders Treatment Global Rheumatic Disorders Treatment Revenue by Region: 2019-2030

3.3.1 Global Rheumatic Disorders Treatment Revenue by Region: 2019-2024

3.3.2 Global Rheumatic Disorders Treatment Revenue by Region: 2025-2030

3.4 North America Rheumatic Disorders Treatment Market Facts & Figures by Country

3.4.1 North America Rheumatic Disorders Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Rheumatic Disorders Treatment Sales by Country (2019-2030)

3.4.3 North America Rheumatic Disorders Treatment Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Rheumatic Disorders Treatment Market Facts & Figures by Country

3.5.1 Europe Rheumatic Disorders Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Rheumatic Disorders Treatment Sales by Country (2019-2030)

3.5.3 Europe Rheumatic Disorders Treatment Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Rheumatic Disorders Treatment Market Facts & Figures by Country

3.6.1 Asia Pacific Rheumatic Disorders Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Rheumatic Disorders Treatment Sales by Country (2019-2030)

3.6.3 Asia Pacific Rheumatic Disorders Treatment Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Rheumatic Disorders Treatment Market Facts & Figures by Country

3.7.1 Latin America Rheumatic Disorders Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Rheumatic Disorders Treatment Sales by Country (2019-2030)

3.7.3 Latin America Rheumatic Disorders Treatment Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Rheumatic Disorders Treatment Market Facts & Figures by Country

3.8.1 Middle East and Africa Rheumatic Disorders Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Rheumatic Disorders Treatment Sales by Country (2019-2030)

3.8.3 Middle East and Africa Rheumatic Disorders Treatment Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Rheumatic Disorders Treatment Sales by Type (2019-2030)

4.1.1 Global Rheumatic Disorders Treatment Sales by Type (2019-2024)

4.1.2 Global Rheumatic Disorders Treatment Sales by Type (2025-2030)

4.1.3 Global Rheumatic Disorders Treatment Sales Market Share by Type (2019-2030)

4.2 Global Rheumatic Disorders Treatment Revenue by Type (2019-2030)

4.2.1 Global Rheumatic Disorders Treatment Revenue by Type (2019-2024)

4.2.2 Global Rheumatic Disorders Treatment Revenue by Type (2025-2030)

4.2.3 Global Rheumatic Disorders Treatment Revenue Market Share by Type (2019-2030)

4.3 Global Rheumatic Disorders Treatment Price by Type (2019-2030)

5 Segment by Application

5.1 Global Rheumatic Disorders Treatment Sales by Application (2019-2030)

5.1.1 Global Rheumatic Disorders Treatment Sales by Application (2019-2024)

5.1.2 Global Rheumatic Disorders Treatment Sales by Application (2025-2030)

5.1.3 Global Rheumatic Disorders Treatment Sales Market Share by Application (2019-2030)

5.2 Global Rheumatic Disorders Treatment Revenue by Application (2019-2030)

5.2.1 Global Rheumatic Disorders Treatment Revenue by Application (2019-2024)

5.2.2 Global Rheumatic Disorders Treatment Revenue by Application (2025-2030)

5.2.3 Global Rheumatic Disorders Treatment Revenue Market Share by Application (2019-2030)

5.3 Global Rheumatic Disorders Treatment Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Humira

6.1.1 Humira Corporation Information

6.1.2 Humira Description and Business Overview

6.1.3 Humira Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Humira Rheumatic Disorders Treatment Product Portfolio

6.1.5 Humira Recent Developments/Updates

6.2 Enbrel

6.2.1 Enbrel Corporation Information

6.2.2 Enbrel Description and Business Overview

6.2.3 Enbrel Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Enbrel Rheumatic Disorders Treatment Product Portfolio

6.2.5 Enbrel Recent Developments/Updates

6.3 Simponi

6.3.1 Simponi Corporation Information

6.3.2 Simponi Description and Business Overview

6.3.3 Simponi Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Simponi Rheumatic Disorders Treatment Product Portfolio

6.3.5 Simponi Recent Developments/Updates

6.4 Remicade

6.4.1 Remicade Corporation Information

6.4.2 Remicade Description and Business Overview

6.4.3 Remicade Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Remicade Rheumatic Disorders Treatment Product Portfolio

6.4.5 Remicade Recent Developments/Updates

6.5 Rituxan

6.5.1 Rituxan Corporation Information

6.5.2 Rituxan Description and Business Overview

6.5.3 Rituxan Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Rituxan Rheumatic Disorders Treatment Product Portfolio

6.5.5 Rituxan Recent Developments/Updates

6.6 Stelara

6.6.1 Stelara Corporation Information

6.6.2 Stelara Description and Business Overview

6.6.3 Stelara Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Stelara Rheumatic Disorders Treatment Product Portfolio

6.6.5 Stelara Recent Developments/Updates

6.7 Cosentyx

6.6.1 Cosentyx Corporation Information

6.6.2 Cosentyx Description and Business Overview

6.6.3 Cosentyx Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Cosentyx Rheumatic Disorders Treatment Product Portfolio

6.7.5 Cosentyx Recent Developments/Updates

6.8 Prolia

6.8.1 Prolia Corporation Information

6.8.2 Prolia Description and Business Overview

6.8.3 Prolia Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Prolia Rheumatic Disorders Treatment Product Portfolio

6.8.5 Prolia Recent Developments/Updates

6.9 Orencia

6.9.1 Orencia Corporation Information

6.9.2 Orencia Description and Business Overview

6.9.3 Orencia Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Orencia Rheumatic Disorders Treatment Product Portfolio

6.9.5 Orencia Recent Developments/Updates

6.10 Actemra

6.10.1 Actemra Corporation Information

6.10.2 Actemra Description and Business Overview

6.10.3 Actemra Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Actemra Rheumatic Disorders Treatment Product Portfolio

6.10.5 Actemra Recent Developments/Updates

6.11 Benlysta

6.11.1 Benlysta Corporation Information

6.11.2 Benlysta Rheumatic Disorders Treatment Description and Business Overview

6.11.3 Benlysta Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Benlysta Rheumatic Disorders Treatment Product Portfolio

6.11.5 Benlysta Recent Developments/Updates

6.12 Forteo

6.12.1 Forteo Corporation Information

6.12.2 Forteo Rheumatic Disorders Treatment Description and Business Overview

6.12.3 Forteo Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Forteo Rheumatic Disorders Treatment Product Portfolio

6.12.5 Forteo Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Rheumatic Disorders Treatment Industry Chain Analysis

7.2 Rheumatic Disorders Treatment Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Rheumatic Disorders Treatment Production Mode & Process

7.4 Rheumatic Disorders Treatment Sales and Marketing

7.4.1 Rheumatic Disorders Treatment Sales Channels

7.4.2 Rheumatic Disorders Treatment Distributors

7.5 Rheumatic Disorders Treatment Customers

8 Rheumatic Disorders Treatment Market Dynamics

8.1 Rheumatic Disorders Treatment Industry Trends

8.2 Rheumatic Disorders Treatment Market Drivers

8.3 Rheumatic Disorders Treatment Market Challenges

8.4 Rheumatic Disorders Treatment Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Rheumatic Disorders Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Rheumatic Disorders Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Rheumatic Disorders Treatment Market Competitive Situation by Manufacturers in 2023

Table 4. Global Rheumatic Disorders Treatment Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Rheumatic Disorders Treatment Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Rheumatic Disorders Treatment Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Rheumatic Disorders Treatment Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Rheumatic Disorders Treatment Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Rheumatic Disorders Treatment, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Rheumatic Disorders Treatment, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Rheumatic Disorders Treatment, Product Type & Application

Table 12. Global Key Manufacturers of Rheumatic Disorders Treatment, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Rheumatic Disorders Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatic Disorders Treatment as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Rheumatic Disorders Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Rheumatic Disorders Treatment Sales by Region (2019-2024) & (K Units)

Table 18. Global Rheumatic Disorders Treatment Sales Market Share by Region (2019-2024)

Table 19. Global Rheumatic Disorders Treatment Sales by Region (2025-2030) & (K Units)

Table 20. Global Rheumatic Disorders Treatment Sales Market Share by Region (2025-2030)

Table 21. Global Rheumatic Disorders Treatment Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Rheumatic Disorders Treatment Revenue Market Share by Region (2019-2024)

Table 23. Global Rheumatic Disorders Treatment Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Rheumatic Disorders Treatment Revenue Market Share by Region (2025-2030)

Table 25. North America Rheumatic Disorders Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Rheumatic Disorders Treatment Sales by Country (2019-2024) & (K Units)

Table 27. North America Rheumatic Disorders Treatment Sales by Country (2025-2030) & (K Units)

Table 28. North America Rheumatic Disorders Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Rheumatic Disorders Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Rheumatic Disorders Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Rheumatic Disorders Treatment Sales by Country (2019-2024) & (K Units)

Table 32. Europe Rheumatic Disorders Treatment Sales by Country (2025-2030) & (K Units)

Table 33. Europe Rheumatic Disorders Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Rheumatic Disorders Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Rheumatic Disorders Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Rheumatic Disorders Treatment Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Rheumatic Disorders Treatment Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Rheumatic Disorders Treatment Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Rheumatic Disorders Treatment Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Rheumatic Disorders Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Rheumatic Disorders Treatment Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Rheumatic Disorders Treatment Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Rheumatic Disorders Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Rheumatic Disorders Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Rheumatic Disorders Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Rheumatic Disorders Treatment Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Rheumatic Disorders Treatment Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Rheumatic Disorders Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Rheumatic Disorders Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Rheumatic Disorders Treatment Sales (K Units) by Type (2019-2024)

Table 51. Global Rheumatic Disorders Treatment Sales (K Units) by Type (2025-2030)

Table 52. Global Rheumatic Disorders Treatment Sales Market Share by Type (2019-2024)

Table 53. Global Rheumatic Disorders Treatment Sales Market Share by Type (2025-2030)

Table 54. Global Rheumatic Disorders Treatment Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Rheumatic Disorders Treatment Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Rheumatic Disorders Treatment Revenue Market Share by Type (2019-2024)

Table 57. Global Rheumatic Disorders Treatment Revenue Market Share by Type (2025-2030)

Table 58. Global Rheumatic Disorders Treatment Price (US$/Unit) by Type (2019-2024)

Table 59. Global Rheumatic Disorders Treatment Price (US$/Unit) by Type (2025-2030)

Table 60. Global Rheumatic Disorders Treatment Sales (K Units) by Application (2019-2024)

Table 61. Global Rheumatic Disorders Treatment Sales (K Units) by Application (2025-2030)

Table 62. Global Rheumatic Disorders Treatment Sales Market Share by Application (2019-2024)

Table 63. Global Rheumatic Disorders Treatment Sales Market Share by Application (2025-2030)

Table 64. Global Rheumatic Disorders Treatment Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Rheumatic Disorders Treatment Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Rheumatic Disorders Treatment Revenue Market Share by Application (2019-2024)

Table 67. Global Rheumatic Disorders Treatment Revenue Market Share by Application (2025-2030)

Table 68. Global Rheumatic Disorders Treatment Price (US$/Unit) by Application (2019-2024)

Table 69. Global Rheumatic Disorders Treatment Price (US$/Unit) by Application (2025-2030)

Table 70. Humira Corporation Information

Table 71. Humira Description and Business Overview

Table 72. Humira Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Humira Rheumatic Disorders Treatment Product

Table 74. Humira Recent Developments/Updates

Table 75. Enbrel Corporation Information

Table 76. Enbrel Description and Business Overview

Table 77. Enbrel Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Enbrel Rheumatic Disorders Treatment Product

Table 79. Enbrel Recent Developments/Updates

Table 80. Simponi Corporation Information

Table 81. Simponi Description and Business Overview

Table 82. Simponi Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Simponi Rheumatic Disorders Treatment Product

Table 84. Simponi Recent Developments/Updates

Table 85. Remicade Corporation Information

Table 86. Remicade Description and Business Overview

Table 87. Remicade Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Remicade Rheumatic Disorders Treatment Product

Table 89. Remicade Recent Developments/Updates

Table 90. Rituxan Corporation Information

Table 91. Rituxan Description and Business Overview

Table 92. Rituxan Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Rituxan Rheumatic Disorders Treatment Product

Table 94. Rituxan Recent Developments/Updates

Table 95. Stelara Corporation Information

Table 96. Stelara Description and Business Overview

Table 97. Stelara Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Stelara Rheumatic Disorders Treatment Product

Table 99. Stelara Recent Developments/Updates

Table 100. Cosentyx Corporation Information

Table 101. Cosentyx Description and Business Overview

Table 102. Cosentyx Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Cosentyx Rheumatic Disorders Treatment Product

Table 104. Cosentyx Recent Developments/Updates

Table 105. Prolia Corporation Information

Table 106. Prolia Description and Business Overview

Table 107. Prolia Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Prolia Rheumatic Disorders Treatment Product

Table 109. Prolia Recent Developments/Updates

Table 110. Orencia Corporation Information

Table 111. Orencia Description and Business Overview

Table 112. Orencia Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Orencia Rheumatic Disorders Treatment Product

Table 114. Orencia Recent Developments/Updates

Table 115. Actemra Corporation Information

Table 116. Actemra Description and Business Overview

Table 117. Actemra Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Actemra Rheumatic Disorders Treatment Product

Table 119. Actemra Recent Developments/Updates

Table 120. Benlysta Corporation Information

Table 121. Benlysta Description and Business Overview

Table 122. Benlysta Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Benlysta Rheumatic Disorders Treatment Product

Table 124. Benlysta Recent Developments/Updates

Table 125. Forteo Corporation Information

Table 126. Forteo Description and Business Overview

Table 127. Forteo Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Forteo Rheumatic Disorders Treatment Product

Table 129. Forteo Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Rheumatic Disorders Treatment Distributors List

Table 133. Rheumatic Disorders Treatment Customers List

Table 134. Rheumatic Disorders Treatment Market Trends

Table 135. Rheumatic Disorders Treatment Market Drivers

Table 136. Rheumatic Disorders Treatment Market Challenges

Table 137. Rheumatic Disorders Treatment Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Rheumatic Disorders Treatment

Figure 2. Global Rheumatic Disorders Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Rheumatic Disorders Treatment Market Share by Type in 2023 & 2030

Figure 4. Acts on TNF-α Product Picture

Figure 5. Acts on Interleukins and Interleukin Receptors Product Picture

Figure 6. Act on Protein Kinase Product Picture

Figure 7. Against Cell Surface Antigens Product Picture

Figure 8. Acts on Hormones and Hormone Receptors Product Picture

Figure 9. Global Rheumatic Disorders Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Rheumatic Disorders Treatment Market Share by Application in 2023 & 2030

Figure 11. Hospital

Figure 12. Pharmacy

Figure 13. Other

Figure 14. Global Rheumatic Disorders Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Rheumatic Disorders Treatment Market Size (2019-2030) & (US$ Million)

Figure 16. Global Rheumatic Disorders Treatment Sales (2019-2030) & (K Units)

Figure 17. Global Rheumatic Disorders Treatment Average Price (US$/Unit) & (2019-2030)

Figure 18. Rheumatic Disorders Treatment Report Years Considered

Figure 19. Rheumatic Disorders Treatment Sales Share by Manufacturers in 2023

Figure 20. Global Rheumatic Disorders Treatment Revenue Share by Manufacturers in 2023

Figure 21. The Global 5 and 10 Largest Rheumatic Disorders Treatment Players: Market Share by Revenue in 2023

Figure 22. Rheumatic Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 23. Global Rheumatic Disorders Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Rheumatic Disorders Treatment Sales Market Share by Country (2019-2030)

Figure 25. North America Rheumatic Disorders Treatment Revenue Market Share by Country (2019-2030)

Figure 26. United States Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Rheumatic Disorders Treatment Sales Market Share by Country (2019-2030)

Figure 29. Europe Rheumatic Disorders Treatment Revenue Market Share by Country (2019-2030)

Figure 30. Germany Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Rheumatic Disorders Treatment Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Rheumatic Disorders Treatment Revenue Market Share by Region (2019-2030)

Figure 37. China Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. China Taiwan Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Rheumatic Disorders Treatment Sales Market Share by Country (2019-2030)

Figure 45. Latin America Rheumatic Disorders Treatment Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Rheumatic Disorders Treatment Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Rheumatic Disorders Treatment Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Rheumatic Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Rheumatic Disorders Treatment by Type (2019-2030)

Figure 55. Global Revenue Market Share of Rheumatic Disorders Treatment by Type (2019-2030)

Figure 56. Global Rheumatic Disorders Treatment Price (US$/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Rheumatic Disorders Treatment by Application (2019-2030)

Figure 58. Global Revenue Market Share of Rheumatic Disorders Treatment by Application (2019-2030)

Figure 59. Global Rheumatic Disorders Treatment Price (US$/Unit) by Application (2019-2030)

Figure 60. Rheumatic Disorders Treatment Value Chain

Figure 61. Rheumatic Disorders Treatment Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Chronic Gout Treatment Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24Y15383

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Anti Cyclic Citrullinated Peptide(Anti-CCP) Antibody Assay Kit Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-28X14149

Wed Aug 14 00:00:00 UTC 2024

Add to Cart

Global Rheumatoid Arthritis Testing Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-33E11182

Tue Aug 06 00:00:00 UTC 2024

Add to Cart

Global Rheumatic Disorders Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-15X13281

Thu Jul 25 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions